BACKGROUND: Although ionizing radiation is an established environmental risk factor for thyroid cancer, the effect of chemotherapy drugs on thyroid cancer risk remains unclear. We evaluated the chemotherapy-related risk of thyroid cancer in childhood cancer survivors and the possible joint effects of chemotherapy and radiotherapy. METHODS: The study included 12,547 five-year survivors of childhood cancer diagnosed during 1970 through 1986. Chemotherapy and radiotherapy information was obtained from medical records, and radiation dose was estimated to the thyroid gland. Cumulative incidence and relative risks were calculated with life-table methods and Poisson regression. Chemotherapy-related risks were evaluated separately by categories of radiation dose. RESULTS: Histologically confirmed thyroid cancer occurred in 119 patients. Thirty years after the first childhood cancer treatment, the cumulative incidence of thyroid cancer was 1.3% (95% CI, 1.0-1.6) for females and 0.6% (0.4-0.8) for males. Among patients with thyroid radiation doses of 20 Gy or less, treatment with alkylating agents was associated with a significant 2.4-fold increased risk of thyroid cancer (95% CI, 1.3-4.5; P = 0.002). Chemotherapy risks decreased as radiation dose increased, with a significant decrease for patients treated with alkylating agents (P(trend) = 0.03). No chemotherapy-related risk was evident for thyroid radiation doses more than 20 Gy. CONCLUSIONS: Treatments with alkylating agents increased thyroid cancer risk, but only in the radiation dose range less than 20 Gy, in which cell sparing likely predominates over cell killing. IMPACT: Our study adds to the evidence for chemotherapy agent-specific increased risks of thyroid cancer, which to date, were mainly thought to be related to prior radiotherapy.
BACKGROUND: Although ionizing radiation is an established environmental risk factor for thyroid cancer, the effect of chemotherapy drugs on thyroid cancer risk remains unclear. We evaluated the chemotherapy-related risk of thyroid cancer in childhood cancer survivors and the possible joint effects of chemotherapy and radiotherapy. METHODS: The study included 12,547 five-year survivors of childhood cancer diagnosed during 1970 through 1986. Chemotherapy and radiotherapy information was obtained from medical records, and radiation dose was estimated to the thyroid gland. Cumulative incidence and relative risks were calculated with life-table methods and Poisson regression. Chemotherapy-related risks were evaluated separately by categories of radiation dose. RESULTS: Histologically confirmed thyroid cancer occurred in 119 patients. Thirty years after the first childhood cancer treatment, the cumulative incidence of thyroid cancer was 1.3% (95% CI, 1.0-1.6) for females and 0.6% (0.4-0.8) for males. Among patients with thyroid radiation doses of 20 Gy or less, treatment with alkylating agents was associated with a significant 2.4-fold increased risk of thyroid cancer (95% CI, 1.3-4.5; P = 0.002). Chemotherapy risks decreased as radiation dose increased, with a significant decrease for patients treated with alkylating agents (P(trend) = 0.03). No chemotherapy-related risk was evident for thyroid radiation doses more than 20 Gy. CONCLUSIONS: Treatments with alkylating agents increased thyroid cancer risk, but only in the radiation dose range less than 20 Gy, in which cell sparing likely predominates over cell killing. IMPACT: Our study adds to the evidence for chemotherapy agent-specific increased risks of thyroid cancer, which to date, were mainly thought to be related to prior radiotherapy.
Authors: F de Vathaire; C Hardiman; A Shamsaldin; S Campbell; E Grimaud; M Hawkins; M Raquin; O Oberlin; I Diallo; J M Zucker; X Panis; J L Lagrange; N Daly-Schveitzer; J Lemerle; J Chavaudra; M Schlumberger; C Bonaïti Journal: Arch Intern Med Date: 1999 Dec 13-27
Authors: Wendy M Leisenring; Ann C Mertens; Gregory T Armstrong; Marilyn A Stovall; Joseph P Neglia; Jennifer Q Lanctot; John D Boice; John A Whitton; Yutaka Yasui Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: Parveen Bhatti; Lene H S Veiga; Cécile M Ronckers; Alice J Sigurdson; Marilyn Stovall; Susan A Smith; Rita Weathers; Wendy Leisenring; Ann C Mertens; Sue Hammond; Debra L Friedman; Joseph P Neglia; Anna T Meadows; Sarah S Donaldson; Charles A Sklar; Leslie L Robison; Peter D Inskip Journal: Radiat Res Date: 2010-10-06 Impact factor: 2.841
Authors: Lois B Travis; Mary Gospodarowicz; Rochelle E Curtis; E Aileen Clarke; Michael Andersson; Bengt Glimelius; Timo Joensuu; Charles F Lynch; Flora E van Leeuwen; Eric Holowaty; Hans Storm; Ingrid Glimelius; Eero Pukkala; Marilyn Stovall; Joseph F Fraumeni; John D Boice; Ethel Gilbert Journal: J Natl Cancer Inst Date: 2002-02-06 Impact factor: 13.506
Authors: Alexandra W van den Belt-Dusebout; Berthe M P Aleman; Gijs Besseling; Marie L de Bruin; Michael Hauptmann; Mars B van 't Veer; Ronald de Wit; Jacques G Ribot; Evert M Noordijk; J Martijn Kerst; Jourik A Gietema; Flora E van Leeuwen Journal: Int J Radiat Oncol Biol Phys Date: 2009-12-01 Impact factor: 7.038
Authors: Cécile M Ronckers; Alice J Sigurdson; Marilyn Stovall; Susan A Smith; Ann C Mertens; Yan Liu; Sue Hammond; Charles E Land; Joseph P Neglia; Sarah S Donaldson; Anna T Meadows; Charles A Sklar; Leslie L Robison; Peter D Inskip Journal: Radiat Res Date: 2006-10 Impact factor: 3.372
Authors: J P Neglia; D L Friedman; Y Yasui; A C Mertens; S Hammond; M Stovall; S S Donaldson; A T Meadows; L L Robison Journal: J Natl Cancer Inst Date: 2001-04-18 Impact factor: 11.816
Authors: Ann C Mertens; Yutaka Yasui; Yan Liu; Marilyn Stovall; Ray Hutchinson; Jill Ginsberg; Charles Sklar; Leslie L Robison Journal: Cancer Date: 2002-12-01 Impact factor: 6.921
Authors: Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: Med Pediatr Oncol Date: 2002-04
Authors: William J Hammond; Todd E Heaton; Benjamin A Farber; Usman A Mahmood; Jill S Gluskin; Suzanne L Wolden; Michael P La Quaglia; Charles A Sklar; Anita P Price Journal: J Pediatr Surg Date: 2017-03-15 Impact factor: 2.545
Authors: G M Dores; R E Curtis; F E van Leeuwen; M Stovall; P Hall; C F Lynch; S A Smith; R E Weathers; H H Storm; D C Hodgson; R A Kleinerman; H Joensuu; T B Johannesen; M Andersson; E J Holowaty; M Kaijser; E Pukkala; L Vaalavirta; S D Fossa; F Langmark; L B Travis; J F Fraumeni; B M Aleman; L M Morton; E S Gilbert Journal: Ann Oncol Date: 2014-07-25 Impact factor: 32.976
Authors: Lois B Travis; Wendy Demark Wahnefried; James M Allan; Marie E Wood; Andrea K Ng Journal: Nat Rev Clin Oncol Date: 2013-03-26 Impact factor: 66.675
Authors: Peter D Inskip; Alice J Sigurdson; Lene Veiga; Parveen Bhatti; Cécile Ronckers; Preetha Rajaraman; Houda Boukheris; Marilyn Stovall; Susan Smith; Sue Hammond; Tara O Henderson; Tanya C Watt; Ann C Mertens; Wendy Leisenring; Kayla Stratton; John Whitton; Sarah S Donaldson; Gregory T Armstrong; Leslie L Robison; Joseph P Neglia Journal: Int J Radiat Oncol Biol Phys Date: 2015-12-15 Impact factor: 7.038
Authors: Lene H S Veiga; Erik Holmberg; Harald Anderson; Linda Pottern; Siegal Sadetzki; M Jacob Adams; Ritsu Sakata; Arthur B Schneider; Peter Inskip; Parveen Bhatti; Robert Johansson; Gila Neta; Roy Shore; Florent de Vathaire; Lena Damber; Ruth Kleinerman; Michael M Hawkins; Margaret Tucker; Marie Lundell; Jay H Lubin Journal: Radiat Res Date: 2016-04-29 Impact factor: 2.841